Symptoms and medication management in the end of life phase of high-grade glioma patients

[1]  M. Taphoorn,et al.  End of life care in high-grade glioma patients in three European countries: a comparative study , 2014, Journal of Neuro-Oncology.

[2]  Susan M. Chang,et al.  The end-of-life phase of high-grade glioma patients: a systematic review , 2014, Supportive Care in Cancer.

[3]  B. Onwuteaka-Philipsen,et al.  Reasons for hospitalisation at the end of life: differences between cancer and non-cancer patients , 2014, Supportive Care in Cancer.

[4]  Muhib Khan,et al.  End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review , 2014, Journal of Neuro-Oncology.

[5]  G. van der Wal,et al.  Symptoms, unbearability and the nature of suffering in terminal cancer patients dying at home: a prospective primary care study , 2013, BMC Family Practice.

[6]  T. Steigleder,et al.  Dying of brain tumours: specific aspects of care , 2013, Current opinion in supportive and palliative care.

[7]  M. Taphoorn,et al.  Seizures in patients with high-grade glioma: a serious challenge in the end-of-life phase , 2013, BMJ Supportive & Palliative Care.

[8]  M. Maltoni,et al.  Palliative sedation in end-of-life care , 2013, Current opinion in oncology.

[9]  Pei-ying Zhang,et al.  Prevalence, intensity, and prognostic significance of common symptoms in terminally ill cancer patients. , 2013, Journal of palliative medicine.

[10]  M. Costantini,et al.  Variation in medication use in cancer patients at the end of life: a cross-sectional analysis , 2013, Supportive Care in Cancer.

[11]  M. Taphoorn,et al.  The end-of-life phase of high-grade glioma patients: dying with dignity? , 2013, The oncologist.

[12]  N. Meidenbauer,et al.  Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review , 2013, Supportive Care in Cancer.

[13]  Carina Lundh Hagelin,et al.  Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion. , 2013, Journal of palliative medicine.

[14]  Damien C Weber,et al.  Epidemiology of glial and non-glial brain tumours in Europe. , 2012, European journal of cancer.

[15]  P. Gagnon,et al.  Delirium prevention in terminal cancer: assessment of a multicomponent intervention , 2012, Psycho-oncology.

[16]  G. van der Wal,et al.  Depression and explicit requests for euthanasia in end-of-life cancer patients in primary care in the Netherlands: a longitudinal, prospective study. , 2011, Family practice.

[17]  M. Taphoorn,et al.  Symptoms and problems in the end-of-life phase of high-grade glioma patients. , 2010, Neuro-oncology.

[18]  A. Fabi,et al.  Supportive care in neurooncology , 2010, Current opinion in oncology.

[19]  Alona Muzikansky,et al.  Early palliative care for patients with metastatic non-small-cell lung cancer. , 2010, The New England journal of medicine.

[20]  F. Shepherd,et al.  Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Gaertner,et al.  Differential palliative care issues in patients with primary and secondary brain tumours , 2009, Supportive Care in Cancer.

[22]  M. Costantini,et al.  Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients' life. Results of an Italian mortality follow-back survey. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[24]  W. Struhal,et al.  The end-of-life hospital setting in patients with glioblastoma. , 2008, Journal of palliative medicine.

[25]  E. Eakin,et al.  Quality of life among patients with a brain tumor and their carers. , 2007, Journal of psychosomatic research.

[26]  C. Lucas,et al.  Palliative care of patients with a primary malignant brain tumour: case review of service use and support provided , 2005, Palliative medicine.

[27]  R. Voltz.  How do patients with primary brain tumours die? , 2003, Palliative medicine.

[28]  Jean Potter,et al.  Symptoms in 400 patients referred to palliative care services: prevalence and patterns , 2003, Palliative medicine.

[29]  K. Hoang-Xuan,et al.  Primary brain tumours in adults , 2003, The Lancet.

[30]  Jan J. Heimans,et al.  Impact of brain tumour treatment on quality of life , 2002, Journal of Neurology.

[31]  P. Hall,et al.  The Last 48 Hours of Life in Long‐Term Care: A Focused Chart Audit , 2002, Journal of the American Geriatrics Society.

[32]  R. Portenoy,et al.  Sedation in the Management of Refractory Symptoms: Guidelines for Evaluation and Treatment , 1994, Journal of palliative care.

[33]  M. Taphoorn,et al.  Measuring health-related quality of life in high-grade glioma patients at the end of life using a proxy-reported retrospective questionnaire , 2013, Journal of Neuro-Oncology.

[34]  M. Taphoorn,et al.  Decision-making in the end-of-life phase of high-grade glioma patients. , 2012, European journal of cancer.

[35]  M. Maschio,et al.  Epilepsy in the end-of-life phase in patients with high-grade gliomas , 2012, Journal of Neuro-Oncology.

[36]  A. Pompili,et al.  End of life issues in brain tumor patients , 2008, Journal of Neuro-Oncology.

[37]  C. Costa,et al.  Effects of Psychotropic Drugs on Seizure Threshold , 2002, Drug safety.

[38]  H. Krouwer,et al.  Management of seizures in brain tumor patients at the end of life. , 2000, Journal of palliative medicine.